Form 8-K - Current report:
SEC Accession No. 0000950170-24-095410
Filing Date
2024-08-12
Accepted
2024-08-12 16:06:38
Documents
13
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crgx-20240812.htm   iXBRL 8-K 40626
2 EX-99.1 crgx-ex99_1.htm EX-99.1 113096
3 GRAPHIC img19376069_0.jpg GRAPHIC 4001
  Complete submission text file 0000950170-24-095410.txt   285883

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crgx-20240812.xsd EX-101.SCH 25802
15 EXTRACTED XBRL INSTANCE DOCUMENT crgx-20240812_htm.xml XML 4891
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 241196768
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)